OceanaGold Reports Fatality at the Didipio Mine
OceanaGold Reports Fatality at the Didipio Mine
PR Newswire
VANCOUVER, BC, Aug. 9, 2024
VANCOUVER, BC, Aug. 9, 2024 /PRNewswire/ - OceanaGold Corporation (TSX: OGC) (OTCQX: OCANF) ("OceanaGold" or the "Company") regrets to inform that, as reported in our second quarter results, a contractor working at our Didipio Mine in the Philippines sustained serious head injuries while attempting to remove a metal blockage from a jaw crusher in late July. Despite medical efforts and care, he recently passed away in hospital. There has been no impact to production as a result of this event.
Gerard Bond, President & CEO of OceanaGold, said "We are all deeply saddened by this tragic event, especially those at Didipio who have lost two colleagues in a short period. Although the two events are unrelated, we are taking immediate action at Didipio to improve the effectiveness of the OurSafe Behaviours safety program, increase hazard identification training - particularly in relation to stored energy - and expand in-field coaching on the identification of critical and high-risk tasks and verification of critical controls. Ensuring the safety of our workforce is paramount."
The Company is supporting the family and colleagues of the deceased during this difficult time.
View original content to download multimedia:https://www.prnewswire.com/news-releases/oceanagold-reports-fatality-at-the-didipio-mine-302219148.html
SOURCE OceanaGold Corporation
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks